0.05Open0.10Pre Close188 Volume13 Open Interest2.50Strike Price940.00Turnover224.02%IV73.92%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0049Delta0.0026Gamma187.90Leverage Ratio-0.0015Theta0.0000Rho-0.92Eff Leverage0.0003Vega
Poseida Therapeutics Stock Discussion
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...
No comment yet